Pediatric drug utilization evaluation of cefepime and piperacillin/tazobactam.

Priengrutai PrasopchoknapapornSophida BoonsathornChonnamet TechasaensiriSujittra ChaisavaneeyakornNopporn Apiwattanakul

Published in: Pediatrics international : official journal of the Japan Pediatric Society (2022)

Drug utilization evaluation could improve the appropriateness of empirical use of cefepime and piperacillin/tazobactam in pediatric patients. Patients in critical care units and with UTIs appeared to be associated with inappropriate empirical treatment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
gram negative
emergency department
patient reported outcomes
drug induced
multidrug resistant
combination therapy
childhood cancer